GPNMB and cancer: In malignancies, therapy‐induced senolytic‐resistant SCs may produce growth factors that promote cancer growth, express immune evasion signals such as GPNMB, and release pro‐fibrotic factors that create a matrix shielding cancers from immune clearance, speculations that also need to be explored.